January 14th, 2016
From: ars technica
by Cassandra Khaw
For any smoker in the UK looking to kick the habit, your favourite medical professional may soon prescribe you an e-cigarette. According to Reuters, British American Tobacco’s e-Voke recently became the first vaping device to be given a drug licence in the UK, meaning it’s officially recognised by the state-funded National Health Service as a “quit smoking medicine.”
“We want to ensure licensed nicotine containing products—including e-cigarettes—which make medicinal claims are available and meet appropriate standards of safety, quality and efficacy to help reduce the harms from smoking,” the Medicines and Healthcare Products Regulatory Agency (MHRA) said in a statement on Monday.
December 23rd, 2015
From: BlastingNews
Quitting Smoking As A New Years Resolution May Be Deterred By Misinformation On E-Cigarettes
The FDA has “passed the buck” on deeming regulations of e-cigarettes to the Office of Information and Regulatory Affairs (OIRA), which operates under the Office of Management and Budget (OMB). Why does this need to be looked at under the Office of Management and Budget?
The e-cigarette regulations, and their likely effects, are of great interest to politicians and the health sector in the United States. Politicians have the Master Settlement Agreement (MSA) funds to protect, and are saying e-cigarettes should be regulated for “the children”. That’s political speak for “we are addicted to tobacco sales“. Passing the buck seems to be the clue.
December 17th, 2015
From: Washington Examiner
By Robert King
A major lobbying effort to shield many e-cigarette products from federal regulation has gone up in smoke.
A $1.1 trillion spending bill released early Wednesday did not include a rider to change the grandfather date in upcoming federal regulations for e-cigarettes.
Read Complete Article
December 10th, 2015
From: CSPnet.com
Provides comments on PMTA applications, potential job losses
Published in Tobacco E-News
By
Thomas A. Briant, NATO Executive Director
MINNEAPOLIS — Since October, officials from the White House Office of Management and Budget (OMB) have been meeting with interested parties that want to provide feedback and/or concerns about the Food and Drug Administration’s (FDA) proposed tobacco deeming regulations. This OMB regulatory review process involves analyzing the economic benefits and costs of proposed federal regulations.
